Medication Fact Sheets
|
December 16, 2024

Diclofenac Sodium Topical Gel: Uses, Effects, and Considerations

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
December 23, 2024

Musculoskeletal pain is one of the most common health complaints, affecting 1.71 billion people globally. For many, oral nonsteroidal anti-inflammatory drugs (NSAIDs) are the go-to solution, offering relief from pain and inflammation. 

However, these medications come with systemic risks, such as gastrointestinal irritation, cardiovascular complications, and kidney issues, particularly with prolonged use. Diclofenac gel provides targeted action and may offer a safer alternative to oral NSAIDs for certain conditions.

[signup]

What Is Diclofenac Sodium Topical Gel?

Diclofenac sodium topical gel is the generic form of a nonsteroidal anti-inflammatory drug (NSAID) formulated for application to the skin. It is also sold under the brand names Voltaren (1% gel) and Solaraze (3% gel).

Unlike oral NSAIDs, which distribute medication throughout the entire body, the gel delivers its therapeutic effects directly to the affected area. This localized application makes it a practical option for managing inflammation and pain associated with specific musculoskeletal conditions.

Mechanism of Action: How Diclofenac Sodium Works

Diclofenac sodium works by interrupting the body's natural inflammation and pain-signaling processes. Inflammation happens when the body senses damage or irritation, such as an injury or arthritis. 

This triggers the release of chemical messengers called prostaglandins, which promote symptoms like pain, swelling, and redness to help protect the body and repair damaged tissues.

Prostaglandins are produced through a process that involves enzymes called cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). These enzymes convert a substance called arachidonic acid into prostaglandins and other molecules that cause inflammation and pain.

Diclofenac blocks the COX enzymes, especially COX-2, which becomes more active during injury or inflammation. By inhibiting these enzymes, diclofenac reduces the production of prostaglandins at the site of inflammation, lowering pain and swelling. 

Beyond its effects on prostaglandins, diclofenac may also help reduce pain by calming overactive pain signals in the nervous system. Evidence suggests it may lower levels of substance P, a molecule associated with amplifying pain.

Common Uses of Diclofenac Sodium Topical Gel

Topical diclofenac is used to manage localized pain and inflammation, offering effective relief for conditions ranging from osteoarthritis to soft tissue injuries like sprains and muscle strains.

Treating Osteoarthritis

Osteoarthritis is a chronic degenerative joint condition characterized by the breakdown of cartilage, the protective tissue at the ends of bones, leading to pain, stiffness, swelling, and reduced mobility. It is the most common form of arthritis and typically affects weight-bearing joints like the knees, hips, and spine, although it can occur in any joint.

The Food and Drug Administration (FDA) has approved diclofenac 1% gel for relieving osteoarthritis pain in joints amenable to topical treatment, such as the knees and hands. It has not been evaluated for use on the spine, hip, or shoulder.

Managing Soft Tissue Injuries 

Diclofenac can be used off-label for myalgia (aches and pains of the muscles and surrounding tissues) (1). Off-label drug use refers to the prescription of a medication for a purpose, dosage, or population that the FDA has not approved.

Studies suggest that applying topical diclofenac 2.3% gel twice daily may help relieve pain, improve joint function, and support recovery from sprains and strains

Actinic Keratosis

Actinic keratosis is a rough, scaly patch of skin caused by prolonged exposure to ultraviolet (UV) radiation. It often appears on sun-exposed areas such as the face, hands, and scalp. It is considered a precancerous condition, as it can progress to squamous cell carcinoma if left untreated.

Diclofenac 3% topical gel is FDA-approved to treat actinic keratosis. Its proposed mechanisms in treating this skin condition are reducing cellular replication by blocking COX-2 and upregulating apoptosis (cell death). (20

Proper Application and Dosage Guidelines

A person should use the lowest effect dose of diclofenac gel for the shortest duration possible.  

Use the dosage card included in the packaging to measure the proper amount of gel. After measuring, rub the gel into the affected area's skin using your fingers. Wait at least one hour before showering to allow the medication to be absorbed. 

Lower Extremities

Apply 4 grams of the 1% gel to the affected area four times daily. Do not apply more than 16 grams daily to a single joint of the lower extremities (including feet, ankles, and knees). Do not exceed a daily dose of 32 grams daily. (29

Upper Extremities

Apply 2 grams of the 1% gel to the affected area four times daily. Do not exceed 8 grams daily to a single joint of the upper extremities (including hands, wrists, and elbows). Do not exceed a daily dose of 32 grams daily. (29)

Actinic Keratosis

Apply 0.5 grams of the 3% gel to lesions twice daily for 60-90 days (24).  

Side Effects and Risks of Diclofenac Sodium Topical Gel

As with any medication, diclofenac sodium topical gel may cause side effects.

Common Side Effects 

The most common side effect associated with using Voltaren and Solaraze gel is localized dermatitis (skin irritation) at the application site (24, 29). 

Other common side effects that don't usually require medical attention include:

  • Irritation at the site of application 
  • Headache
  • Nausea
  • Loss of appetite
  • Upset stomach

Serious Side Effects

Contact your healthcare provider if you experience any of the following (1, 6): 

  • Allergic Reaction: skin rash, itching, hives, swelling of the face or throat, difficulty breathing
  • Asthma Attack: chest pain, cough, difficulty breathing 
  • Hypertension: new-onset or a worsening of high blood pressure
  • Kidney Injury: reduced urine output, swelling of the extremities
  • Liver Injury: right upper abdominal pain, nausea, light-colored stool, dark yellow or brown urine, yellowing of the skin, fatigue

Warnings

The FDA has issued several warnings regarding the use of diclofenac sodium topical gel. 

Cardiovascular Events

NSAIDs, including topical diclofenac, may be associated with an increased risk of cardiovascular thrombotic events such as heart attack and stroke, which can be life-threatening. This risk may occur early in treatment and may increase with the duration of use. 

Seek emergency medical care if you experience any of these symptoms:

  • Chest pain
  • Shortness of breath
  • Weakness in one part of side of the body
  • Slurred speech

Gastrointestinal Events

NSAIDs can cause serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. This risk is higher for people who have used NSAIDs for a long time, are at least 60 years old, have poor health, smoke, or drink alcohol. 

Stop using diclofenac and call your doctor if you experience any of the following symptoms:

  • Stomach pain
  • Heartburn
  • Vomiting blood
  • Bright red blood in the stool
  • Back, tarry stools

Interactions With Other Medications

Drug interactions occur when one medication affects the action, absorption, metabolism, or side effects of another, altering its effectiveness or increasing the risk of adverse effects. 

Using diclofenac topical gel with the following medicines is not recommended:

  • Using diclofenac while taking drugs that affect blood clotting, such as warfarin, aspirin, or SSRI/SNRI antidepressants, may increase the risk of bleeding. Examples include warfarin, aspirin, and SSRI/SNRI antidepressants. 
  • Diclofenac can diminish the blood pressure-lowering effects of ACE inhibitors, angiotensin receptor blockers, or beta-blockers
  • Concomitant use of diclofenac with other NSAIDs (e.g., aspirin, ibuprofen, naproxen) increases the risk of GI toxicity. 
  • NSAIDs reduce the effects of loop and thiazide diuretics (e.g., furosemide, hydrochlorathiazide).
  • Diclofenac increases the serum concentration of digoxin.
  • NSAIDs may increase the serum concentration and reduce the clearance of lithium, resulting in lithium toxicity.
  • NSAIDs may increase the risk of methotrexate toxicity.
  • Using diclofenac gel with cyclosporine increases the risk of cyclosporine nephrotoxicity (kidney damage).

Note: This is not a complete list of all possible drug interactions associated with diclofenac. Before using topical diclofenac gel, give your doctor a list of all medications, herbs, and dietary supplements you use to prevent adverse effects associated with drug interactions.

Who Should Avoid Diclofenac Sodium Topical Gel?

Diclofenac is not safe for everyone. Special considerations should be taken for certain populations. 

Contraindications

A drug contraindication is a specific situation in which the use of a particular medication is not advised because it could cause harm or adverse effects. Diclofenac sodium topical gel is not recommended for individuals with:

  • History of allergy, asthma, or urticaria (hives) after taking diclofenac or any other NSAIDs
  • Coronary artery bypass graft (CABG) surgery

High-Risk Groups

Pregnancy: Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding before using diclofenac. Diclofenac is classified as Pregnancy Category C* prior to 30 weeks gestation and Category D** after 30 weeks gestation. Using diclofenac while pregnant can cause serious harm to the baby. (7

*Pregnancy Class C: Animal studies have shown adverse effects on the fetus, but there are no well-controlled studies in humans (12).

**Pregnancy Class D: Sufficient evidence from human studies and post-marketing data has demonstrated a risk to the fetus (12).

Elderly: Diclofenac is listed in the Beers Criteria, a guideline developed by the American Geriatrics Society (AGS) to identify potentially inappropriate medications for use in older adults. Using diclofenac in older adults increases the risk of serious GI complications (especially in those with a history of peptic ulcer disease), cardiovascular events, and kidney dysfunction. (7

If diclofenac is deemed necessary, it should be used at the lowest effective dose and for the shortest duration possible, with close monitoring for any signs of adverse effects (7). 

Comparison: Diclofenac Sodium Topical Gel vs. Other Pain Relief Methods

Topical diclofenac gel is a commonly used option for pain management, with studies suggesting it offers comparable efficacy to other NSAIDs and a potentially reduced risk of systemic side effects compared to oral NSAIDs.

A comprehensive review of randomized controlled trials involving over 3,000 patients demonstrated that topical diclofenac significantly reduces the pain and inflammation associated with acute and chronic conditions, with efficacy comparable to other topical NSAIDs and some oral NSAIDs like ibuprofen and naproxen.

Other studies have found diclofenac to be more effective than other topical NSAIDs, such as ibuprofen and ketoprofen, in reducing pain (16). 

The American Society of Pain and Neuroscience recommends using topical diclofenac 70-81 mg/day as first-line pharmacologic treatment for osteoarthritis of the knee over oral NSAIDs due to reduced systemic exposure and similar efficacy.

Non-Pharmacological Methods

Non-pharmacological methods also play a role in treating musculoskeletal pain. Diclofenac gel can often complement these methods, offering an integrated approach to pain management.

According to the 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee, exercise therapy is strongly recommended for knee and hip osteoarthritis due to its efficacy in reducing pain and improving function. This includes aerobic, aquatic, and resistance exercises.

Low-level laser therapy (LLLT) is a non-invasive treatment that stimulates cellular activity and promotes tissue healing. LLLT reduces joint pain, stiffness, swelling, and joint function in patients with osteoarthritis. The therapy works by decreasing inflammatory markers, enhancing blood flow, and stimulating the repair of damaged cartilage and soft tissues. (10)

By inserting thin needles into specific points on the body, acupuncture stimulates nerve endings, enhances blood flow, and releases endorphins (the body's natural painkillers). Studies have shown that acupuncture can reduce pain and improve joint function in osteoarthritis patients, particularly for knee osteoarthritis

[signup]

Key Takeaways

  • Diclofenac sodium topical gel may be a practical and versatile option for managing localized pain and inflammation.
  • Its targeted action, combined with a favorable safety profile, makes it a valuable choice for patients with conditions like osteoarthritis or soft tissue injuries. 
  • Healthcare professionals play a role in educating patients about the benefits and risks of diclofenac gel, ensuring its safe and effective use. 
  • Patients should consult their healthcare provider for more information about this treatment option.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Alfaro, R. A., & Modi, P. V. (2023). Diclofenac. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557879/
  2. American Geriatrics Society. (2023). American Geriatrics Society 2023 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 71(7). https://doi.org/10.1111/jgs.18372
  3. Atzeni, F., Masala, I. F., & Sarzi-Puttini, P. (2018). A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac. Pain and Therapy, 7(2), 163–177. https://doi.org/10.1007/s40122-018-0100-2
  4. Bouck, Z., Mecredy, G. C., Ivers, N. M., et al. (2018). Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease. JAMA Internal Medicine, 178(11), 1516. https://doi.org/10.1001/jamainternmed.2018.4273
  5. Cloyd, J. (2022, August 17). An Integrative Medicine Approach to Rheumatology. Rupa Health. https://www.rupahealth.com/post/6-common-types-of-arthritis
  6. Diclofenac Topical Solution. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/20130-diclofenac-topical-solution
  7. DICLOFENAC SODIUM- diclofenac sodium topical gel, 1%, gel. (2024). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aee20924-79ab-400e-b9b6-418978914654
  8. Diclofenac Topical (arthritis pain). MedlinePlus. https://medlineplus.gov/druginfo/meds/a611002.html
  9. Diorio, B. (2023, February 21). What is Integrative Medicine Pain Management? Rupa Health. https://www.rupahealth.com/post/what-is-integrative-medicine-pain-management
  10. Dombrowski, A., Imre, K., Yan, M., et al. (2018). Treatment of Osteoarthritis With Low-level Laser Therapy, Acupuncture, and Herbal Therapy: A Case Report. Integrative Medicine: A Clinician's Journal, 17(2), 48. https://pmc.ncbi.nlm.nih.gov/articles/PMC6396761/
  11. Drug Interactions: What You Should Know. (2020, March 17). U.S. Food & Drug Administration. https://www.fda.gov/drugs/resources-drugs/drug-interactions-what-you-should-know
  12. FDA Pregnancy Categories. (2021). CHEMM. https://chemm.hhs.gov/pregnancycategories.htm
  13. Fitzpatrick, F. A. (2004). Cyclooxygenase enzymes: regulation and function. Current Pharmaceutical Design, 10(6), 577–588. https://doi.org/10.2174/1381612043453144
  14. Hunter, C. W., Deer, T. R., Jones, M. R., et al. (2022). Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience. Journal of Pain Research, 15, 2683–2745. https://doi.org/10.2147/JPR.S370469
  15. Kolasinski, S. L., Neogi, T., Hochberg, M. C., et al. (2020). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology, 72(2), 220–233. https://doi.org/10.1002/art.41142
  16. McMahon, S. B., Dargan, P., Lanas, A., et al. (2020). The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Current Medical Research and Opinion, 37(2), 1–11. https://doi.org/10.1080/03007995.2020.1847718
  17. Musculoskeletal health. (2022, July 14). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions
  18. Myalgia. (2019). Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/myalgia
  19. NCI Dictionary of Cancer Terms. (2011, February 2). National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/contraindication
  20. Nelson, C. (2011). Diclofenac gel in the treatment of actinic keratoses. Therapeutics and Clinical Risk Management, 7, 207–211. https://doi.org/10.2147/tcrm.s12498
  21. Off-Label Drugs: What You Need to Know. Agency for Health Research and Quality. https://www.ahrq.gov/patients-consumers/patient-involvement/off-label-drug-usage.html
  22. Prostaglandins. (2022, November 4). Cleveland Clinic. https://my.clevelandclinic.org/health/articles/24411-prostaglandins
  23. Selfe, T. K., & Taylor, A. G. (2008). Acupuncture and Osteoarthritis of the Knee. Family & Community Health, 31(3), 247–254. https://doi.org/10.1097/01.fch.0000324482.78577.0f
  24. Solaraze HIGHLIGHTS OF PRESCRIBING INFORMATION. U.S. Food and Drug Administration. Retrieved December 9, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s023lbl.pdf
  25. Sprains and strains. (2014). Mount Sinai Health System. https://www.mountsinai.org/health-library/condition/sprains-and-strains
  26. Stanford, J. (2024, June 20). NSAIDs Fact Sheet: Uses, Benefits, Risks, and More. Rupa Health. https://www.rupahealth.com/post/nsaids-fact-sheet
  27. Substance P. ScienceDirect. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/substance-p
  28. Tieppo Francio, V., Davani, S., Towery, C., et al. (2017). Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis. Journal of Pain & Palliative Care Pharmacotherapy, 31(2), 113–120. https://doi.org/10.1080/15360288.2017.1301616
  29. Voltaren Gel HIGHLIGHTS OF PRESCRIBING INFORMATION. (2016). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022122s010lbl.pdf
  30. Weinberg, J. L. (2023, June 21). A comprehensive review of integrative approaches for the treatment of osteoarthritis: Diagnosis, differential diagnosis, and therapy options. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-treatment-of-osteoarthritis-a-comprehensive-review
  31. Weinberg, J. L. (2023, August 2). Integrative Dermatology Approaches to Actinic Keratosis. Rupa Health. https://www.rupahealth.com/post/integrative-dermatology-approaches-to-actinic-keratosis
  32. Weinberg, J. L. (2024, February 27). A Functional Medicine Approach to Squamous Cell Skin Cancer. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-squamous-cell-skin-cancer
  33. Yoshimura, H. (2023, April 11). Using Acupuncture for Chronic Pain Management. Rupa Health. https://www.rupahealth.com/post/using-acupuncture-for-chronic-pain-management
  34. Yoshimura, H. (2023, October 10). A Root Cause Medicine Approach to Chronic Inflammation. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-approach-to-chronic-inflammation
  35. Zacher, J., Altman, R., Bellamy, N., et al. (2008). Topical diclofenac and its role in pain and inflammation: an evidence-based review. Current Medical Research and Opinion, 24(4), 925–950. https://doi.org/10.1185/030079908x273066
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.